CIK 0001819790
- Large accelerated filer
Tarsus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- TARS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 814717861
- Phone
- +1 949-409-9820
- Business address
- 15440 LAGUNA CANYON ROAD, IRVINE, CA, 92618
- 4 Option exercise Director acquired 2,000 shares (option exercise)
- 4 Planned sale President/CEO and Board Chair sold 9,000 shares at $18.58 ($167,220)
- 4 Planned sale President/CEO and Board Chair sold 3,100 shares at $20.01 ($62,031)
- 4 Planned sale Chief Commercial Officer sold 100 shares at $20.00 ($2,000)
- 4 Planned sale Chief Commercial Officer sold 4,643 shares at an average $19.00 ($88,231)
- 4 Planned sale President/CEO and Board Chair sold 8,000 shares at $15.90 ($127,200)
- 4 Other disposition Director disposed of 215,576 shares (other)
- 4 Planned sale President/CEO and Board Chair sold 9,000 shares at $16.80 ($151,200)
- 4 Planned sale President/CEO and Board Chair sold 10,119 shares at an average $15.11 ($152,925)
- 3/A Insider 3/A
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale President/CEO and Board Chair sold 2,311 shares at $15.03 ($34,734)
- 4 Planned sale Chief Financial Officer sold 5,000 shares at $14.02 ($70,100)
- 4 Planned sale President/CEO and Board Chair sold 8,000 shares at $13.60 ($108,800)
- 4 Open-market sale Chief Financial Officer sold 1,004 shares at an average $12.55 ($12,603)
- 4 Open-market sale CHIEF MEDICAL OFFICER sold 1,513 shares at an average $12.58 ($19,026)
- 4 Open-market sale Chief Operating Officer sold 1,141 shares at an average $12.55 ($14,324)
- 4 Open-market sale General Counsel sold 1,078 shares at an average $12.55 ($13,532)
- 4 Open-market sale President/CEO and Board Chair sold 2,125 shares at an average $12.55 ($26,669)
Page 9 of 17 · 330 filings